Liver diseases in pregnancy: Diseases unique to pregnancy

World Journal of Gastroenterology

Volumn 19, Issue 43, 2013, Pages 7639-7646

  Ahmed, Khulood T ^a   Almashhrawi, Ashraf A ^a   Rahman, Rubayat N ^a   Hammoud, Ghassan M ^a   Ibdah, Jamal A ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Acute fatty liver; And a low platelet count; Eclampsia; Elevated liver enzymes; Hemolysis; Hyperemesis gravidarum; Intrahepatic cholestasis; Liver; Preeclampsia; Pregnancy

Indexed keywords

AMINOTRANSFERASE; ANTIHISTAMINIC AGENT; BETAMETHASONE; COLESTYRAMINE; ENOYL COENZYME A HYDRATASE; ESTRADIOL 17 GLUCURONIDE; MAGNESIUM SULFATE; OPIATE ANTAGONIST; SERUM ALBUMIN; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; DEHYDRATION; ECLAMPSIA; EPIGASTRIC PAIN; FATTY LIVER; GENETIC PREDISPOSITION; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERTENSION; HYPERTRANSAMINASEMIA; HYPOGLYCEMIA; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; MALABSORPTION; PLASMAPHERESIS; PREECLAMPSIA; PREGNANCY; PROGNOSIS; PROTEINURIA; PRURITUS; REVIEW; SEIZURE; STEATORRHEA; VOMITING;

ACUTE FATTY LIVER; ECLAMPSIA; HEMOLYSIS, ELEVATED LIVER ENZYMES, AND A LOW PLATELET COUNT; HYPEREMESIS GRAVIDARUM; INTRAHEPATIC CHOLESTASIS; LIVER; PREECLAMPSIA; PREGNANCY;

FEMALE; HUMANS; LIVER DISEASES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS;

EID: 84888115227     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i43.7639     Document Type: Review

References (104)

1. Weigel MM, Weigel RM. Nausea and vomiting of early pregnancy and pregnancy outcome. An epidemiological study. Br J Obstet Gynaecol 1989; 96: 1304-1311 [PMID: 2611169]
2. Philip B. Hyperemesis gravidarum: literature review. WMJ 2003; 102: 46-51 [PMID: 12822290]
3. Koch KL, Frissora CL. Nausea and vomiting during pregnancy. Gastroenterol Clin North Am 2003; 32: 201-234, vi [PMID: 12635417]
4. Abell TL, Riely CA. Hyperemesis gravidarum. Gastroenterol Clin North Am 1992; 21: 835-849 [PMID: 1478739]
5. Wong HY, Tan JY, Lim CC. Abnormal liver function tests in the symptomatic pregnant patient: the local experience in Singapore. Ann Acad Med Singapore 2004; 33: 204-208 [PMID: 15098635]
6. Veenendaal MV, van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG 2011; 118: 1302-1313 [PMID: 21749625 DOI: 10.1111/ j.1471-0528.2011.03023.x]
7. Dodds L, Fell DB, Joseph KS, Allen VM, Butler B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol 2006; 107: 285-292 [PMID: 16449113 DOI: 10.1097/01.aog.0000195060.22832.cd]
8. Morali GA, Braverman DZ. Abnormal liver enzymes and ketonuria in hyperemesis gravidarum. A retrospective review of 80 patients. J Clin Gastroenterol 1990; 12: 303-305 [PMID: 2362099]
9. Adams RH, Gordon J, Combes B. Hyperemesis gravidarum. I. Evidence of hepatic dysfunction. Obstet Gynecol 1968; 31: 659-664 [PMID: 5646397]
10. Outlaw WM, Ibdah JA. Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum. Med Hypotheses 2005; 65: 1150-1153 [PMID: 16040200 DOI: 10.1016/j.mehy.2005.05.035]
11. Ibdah JA, Yang Z, Bennett MJ. Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 2000; 71: 182-189 [PMID: 11001809 DOI: 10.1006/mgme.2000.3065]
12. Schoeman MN, Batey RG, Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 1991; 100: 544-548 [PMID: 1985050]
13. Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998; 178: 603-608 [PMID: 9539533]
14. Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999; 340: 1723-1731 [PMID: 10352164 DOI: 10.1056/ nejm199906033402204]
15. Innes AM, Seargeant LE, Balachandra K, Roe CR, Wanders RJ, Ruiter JP, Casiro O, Grewar DA, Greenberg CR. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res 2000; 47: 43-45 [PMID: 10625081]
16. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 2003; 284: E1098-E1105 [PMID: 12582009 DOI: 10.1152/ajpendo. 00481.2002]
17. Conchillo JM, Koek GH. Hyperemesis gravidarum and severe liver enzyme elevation. J Hepatol 2002; 37: 162-163 [PMID: 12076879]
18. Orazi G, Dufour PH, Puech F. Jaundice induced by hyperemesis gravidarum. Int J Gynaecol Obstet 1998; 61: 181-183 [PMID: 9639224]
19. Larrey D, Rueff B, Feldmann G, Degott C, Danan G, Benhamou JP. Recurrent jaundice caused by recurrent hyperemesis gravidarum. Gut 1984; 25: 1414-1415 [PMID: 6510771]
20. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med 1996; 335: 569-576 [PMID: 8678935 DOI: 10.1056/ nejm199608223350807]
21. Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, Katz R, Medina E. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978; 88: 487-493 [PMID: 637428]
22. Reyes H, Taboada G, Ribalta J. Prevalence of intrahepatic cholestasis of pregnancy in La Paz, Bolivia. J Chronic Dis 1979; 32: 499-504 [PMID: 457835]
23. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049-2066 [PMID: 19418576]
24. Marschall HU, Wikström Shemer E, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: A population-based cohort study. Hepatology 2013; 58: 1385-1391 [PMID: 23564560 DOI: 10.1002/hep.26444]
25. Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, Hirvioja ML, Riikonen S, Ylikorkala O, Lehesjoki AE, Williamson C, Aittomäki K. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52: 1025-1029 [PMID: 12801961]
26. Müllenbach R, Linton KJ, Wiltshire S, Weerasekera N, Chambers J, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: e70 [PMID: 12746424]
27. Gendrot C, Bacq Y, Brechot MC, Lansac J, Andres C. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: e32 [PMID: 12624161]
28. Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, de Swiet M, Warnes G, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9: 1209-1217 [PMID: 10767346]
29. Bacq Y, Gendrot C, Perrotin F, Lefrou L, Chrétien S, Vie-Buret V, Brechot MC, Andres CR. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J Med Genet 2009; 46: 711-715 [PMID: 19584064 DOI: 10.1136/jmg.2009.067397]
30. Dixon PH, van Mil SW, Chambers J, Strautnieks S, Thompson RJ, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson LA, Marschall HU, Molokhia M, Moore GE, Linton KJ, Williamson C. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009; 58: 537-544 [PMID: 18987030 DOI: 10.1136/gut.2008.159541]
31. Müllenbach R, Bennett A, Tetlow N, Patel N, Hamilton G, Cheng F, Chambers J, Howard R, Taylor-Robinson SD, Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005; 54: 829-834 [PMID: 15888793 DOI: 10.1136/gut.2004.058115]
32. Painter JN, Savander M, Ropponen A, Nupponen N, Riikonen S, Ylikorkala O, Lehesjoki AE, Aittomäki K. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur J Hum Genet 2005; 13: 435-439 [PMID: 15657619 DOI: 10.1038/sj.ejhg.5201355]
33. Kreek MJ. Female sex steroids and cholestasis. Semin Liver Dis 1987; 7: 8-23 [PMID: 3296217 DOI: 10.1055/ s-2008-1040559]
34. Reyes H, Sjövall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000; 32: 94-106 [PMID: 10766400]
35. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL. The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255-264 [PMID: 9207286]
36. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000; 118: 422-430 [PMID: 10648470]
37. Giusti G, Piccinino F, Ricciardi I, Delrio G, Sagnelli E, Manzillo G. Abnormal steroid sulfate in plasma of women with intrahepatic cholestasis of pregnancy. Acta Hepatogastroenterol (Stuttg) 1979; 26: 203-206 [PMID: 484169]
38. Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med 2008; 10: e9 [PMID: 18371245 DOI: 10.1017/ s1462399408000628]
39. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012-1021 [PMID: 11131439]
40. Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomäki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006; 43: 723-728 [PMID: 16557542 DOI: 10.1002/hep.21111]
41. Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26: 358-364 [PMID: 9252146 DOI: 10.1002/hep.510260216]
42. Lunzer M, Barnes P, Byth K, O'Halloran M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986; 91: 825-829 [PMID: 3743960]
43. Bacq Y. Liver diseases unique to pregnancy: a 2010 update. Clin Res Hepatol Gastroenterol 2011; 35: 182-193 [PMID: 21310683 DOI: 10.1016/j.clinre.2010.11.011]
44. IBER FL. JAUNDICE IN PREGNANCY--A REVIEW. Am J Obstet Gynecol 1965; 91: 721-753 [PMID: 14268788]
45. Bergasa NV. The pruritus of cholestasis. Semin Dermatol 1995; 14: 302-312 [PMID: 8679436]
46. Frezza M, Pozzato G, Chiesa L, Stramentinoli G, di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 1984; 4: 274-278 [PMID: 6706301]
47. Frezza M, Centini G, Cammareri G, Le Grazie C, Di Padova C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990; 37 Suppl 2: 122-125 [PMID: 2083923]
48. Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, Ghidini A. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG 2004; 111: 17-21 [PMID: 14687046]
49. Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005; 129: 894-901 [PMID: 16143129 DOI: 10.1053/j.gastro.2005.06.019]
50. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-531 [PMID: 12198643 DOI: 10.1053/jhep.2002.36088]
51. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, Germain AM. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890-895 [PMID: 8141222]
52. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399-1405 [PMID: 16317669 DOI: 10.1002/ hep.20952]
53. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40: 467-474 [PMID: 15368452 DOI: 10.1002/hep.20336]
54. Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, Bull L. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One 2012; 7: e28343 [PMID: 22403605 DOI: 10.1371/ journal.pone.0028343]
55. Royal College of Obstetricians and Gynecologists. Obstetric cholestasis. London (UK): RCOG Green-top Guideline 2011, No. 43: 7
56. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet 2010; 375: 594-605 [PMID: 20159293 DOI: 10.1016/s0140-6736(09)61495-1]
57. Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 2007; 13: 6226-6230 [PMID: 18069764]
58. Riely CA. Acute fatty liver of pregnancy. Semin Liver Dis 1987; 7: 47-54 [PMID: 3296215 DOI: 10.1055/s-2008-1040563]
59. Pockros PJ, Peters RL, Reynolds TB. Idiopathic fatty liver of pregnancy: findings in ten cases. Medicine (Baltimore) 1984; 63: 1-11 [PMID: 6690883]
60. Castro MA, Goodwin TM, Shaw KJ, Ouzounian JG, McGehee WG. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 1996; 174: 211-216 [PMID: 8572009]
61. Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006; 12: 7397-7404 [PMID: 17167825]
62. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995; 92: 841-845 [PMID: 7846063]
63. Treem WR, Shoup ME, Hale DE, Bennett MJ, Rinaldo P, Millington DS, Stanley CA, Riely CA, Hyams JS. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Gastroenterol 1996; 91: 2293-2300 [PMID: 8931405]
64. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, Jackson S, Turnbull DM. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994; 19: 339-345 [PMID: 8294091]
65. Isaacs JD, Sims HF, Powell CK, Bennett MJ, Hale DE, Treem WR, Strauss AW. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: molecular characterization of a novel maternal mutant allele. Pediatr Res 1996; 40: 393-398 [PMID: 8865274 DOI: 10.1203/00006450-199609000-00005]
66. Yang Z, Zhao Y, Bennett MJ, Strauss AW, Ibdah JA. Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol 2002; 187: 715-720 [PMID: 12237653]
67. Buytaert IM, Elewaut GP, Van Kets HE. Early occurrence of acute fatty liver in pregnancy. Am J Gastroenterol 1996; 91: 603-604 [PMID: 8633521]
68. Monga M, Katz AR. Acute fatty liver in the second trimester of pregnancy. Prim Care Update Ob Gyns 1998; 5: 191 [PMID: 10838361]
69. Monga M, Katz AR. Acute fatty liver in the second trimester. Obstet Gynecol 1999; 93: 811-813 [PMID: 10912403]
70. Suzuki S, Watanabe S, Araki T. Acute fatty liver of pregnancy at 23 weeks of gestation. BJOG 2001; 108: 223-224 [PMID: 11236125]
71. Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 1993; 341: 407-408 [PMID: 8094173]
72. Mjahed K, Charra B, Hamoudi D, Noun M, Barrou L. Acute fatty liver of pregnancy. Arch Gynecol Obstet 2006; 274: 349-353 [PMID: 16868757 DOI: 10.1007/s00404-006-0203-6]
73. Vigil-de Gracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med 2011; 24: 1143-1146 [PMID: 21668324 DOI: 10.3109/14767058.2010.531325]
74. Holzbach RT. Acute fatty liver of pregnancy with disseminated intravascular coagulation. Obstet Gynecol 1974; 43: 740-744 [PMID: 4545029]
75. Burroughs AK, Seong NH, Dojcinov DM, Scheuer PJ, Sherlock SV. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 1982; 51: 481-497 [PMID: 7156326]
76. Cano RI, Delman MR, Pitchumoni CS, Lev R, Rosenthal WS. Acute fatty liver of pregnancy. Complication by disseminated intravascular coagulation. JAMA 1975; 231: 159-161 [PMID: 1172681]
77. Kueh YK, Wang TL, Yeo TC, Guan R. A non-fatal case report of acute fatty liver of pregnancy. Ann Acad Med Singapore 1991; 20: 789-791 [PMID: 1803970]
78. Hsiung R, Hasselmann M, Lutun P, Gordji M. Acute fatty liver of pregnancy. Diagnostic value of hyperuricemia in the pre-jaundice stage. J Gynecol Obstet Biol Reprod (Paris) 1988; 17: 901-905 [PMID: 3221052]
79. Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008; 57: 951-956 [PMID: 18332072 DOI: 10.1136/gut.2008.148676]
80. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876-880 [PMID: 12427793]
81. Goel A, Ramakrishna B, Zachariah U, Ramachandran J, Eapen CE, Kurian G, Chandy G. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis? Gut 2011; 60: 138-139; author reply 139-140 [PMID: 20938054 DOI: 10.1136/gut.2009.198465]
82. Minakami H, Takahashi T, Tamada T. Should routine liver biopsy be done for the definite diagnosis of acute fatty liver of pregnancy? Am J Obstet Gynecol 1991; 164: 1690-1691 [PMID: 1878069]
83. Seyyed Majidi MR, Vafaeimanesh J. Plasmapheresis in acute Fatty liver of pregnancy: an effective treatment. Case Rep Obstet Gynecol 2013; 2013: 615975 [PMID: 23424692 DOI: 10.1155/2013/615975]
84. Dovlatian AA, Bentsianov VA. Plasmapheresis in the treatment of complicated forms of acute suppurative pyelonephritis in pregnant women. Urol Nefrol (Mosk) 1995; (1): 22-25 [PMID: 7732626]
85. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163: 1691-1712 [PMID: 2104525]
86. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22 [PMID: 10920346]
87. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991; 165: 1408-1412 [PMID: 1957870]
88. Rolfes DB, Ishak KG. Liver disease in toxemia of pregnancy. Am J Gastroenterol 1986; 81: 1138-1144 [PMID: 3788923]
89. Arias F, Mancilla-Jimenez R. Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. N Engl J Med 1976; 295: 578-582 [PMID: 950973 DOI: 10.1056/ nejm197609092951102]
90. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160: 1405-1423 [PMID: 11943725 DOI: 10.1016/s0002-9440(10)62567-9]
91. Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998; 53: 377-382 [PMID: 9618714]
92. Pollitt RJ. Disorders of mitochondrial long-chain fatty acid oxidation. J Inherit Metab Dis 1995; 18: 473-490 [PMID: 7494405]
93. Barton JR, Sibai BM. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1996; 174: 1820-1825; discussion 1825-1827 [PMID: 8678146]
94. Barton JR, Sibai BM. Gastrointestinal complications of preeclampsia. Semin Perinatol 2009; 33: 179-188 [PMID: 19464509 DOI: 10.1053/j.semperi.2009.02.006]
95. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000-1006 [PMID: 8238109]
96. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103: 981-991 [PMID: 15121574 DOI: 10.1097/01.aog.0000126245.35811.2a]
97. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183: 444-448 [PMID: 10942484 DOI: 10.1067/mob.2000.105915]
98. MacKenna J, Dover NL, Brame RG. Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets--an obstetric emergency? Obstet Gynecol 1983; 62: 751-754 [PMID: 6634002]
99. Heller CS, Elliott JP. High-order multiple pregnancies complicated by HELLP syndrome. A report of four cases with corticosteroid therapy to prolong gestation. J Reprod Med 1997; 42: 743-746 [PMID: 9408876]
100. Martin JN, Blake PG, Perry KG, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500-1509; discussion 1509-1513 [PMID: 2048596]
101. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 1995; 273: 413-418 [PMID: 7823388]
102. Heyborne KD, Burke MS, Porreco RP. Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases. J Reprod Med 1990; 35: 53-57 [PMID: 2299613]
103. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999; 181: 304-309 [PMID: 10454673]
104. Varol F, Aydin T, Gücer F. HELLP syndrome and postpartum corticosteroids. Int J Gynaecol Obstet 2001; 73: 157-159 [PMID: 11336737]